Still Not a Bad Sum | GenomeWeb

Still Not a Bad Sum

Senior officials at Massachusetts General and Brigham and Women's Hospitals are restricted to receiving no more than $5,000 a day for working on boards of pharmaceutical or biotechnology companies, reports the New York Times. Partners HealthCare forbidding employees from accepting speaker fees from drug companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.